₹ 2.6 Cr
Volume transacted
15.3 K
stocks traded
Last Updated time: 17 Sep 14:43 PM
Glenmark Pharmaceuticals Ltd
BSE
17 Sep, 2024
1720.05-21.8 (-1.3%)
Prev Close
1741.85
Open Price
1739.5
Bid Price (QTY)
1720.8 (0)
Offer Price (QTY)
1720.0 (0)
Volume
15324
Today's High / Low
1745.9 / 1716.0
52 WK High / Low
1773.9 / 702.0
NSE
17 Sep, 2024
1720.95-20.5 (-1.2%)
Prev Close
1741.45
Open Price
1745
Bid Price (QTY)
1720.9 (1)
Offer Price (QTY)
1720.9 (6)
Volume
613699
Today's High / Low
1746.8 / 1715.1
52 WK High / Low
1769.6 / 722.1
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
16 Sep 2024 | 1741.85 | 1773.95 | 1773.95 | 1734.35 |
13 Sep 2024 | 1752.35 | 1749.45 | 1756.2 | 1728.55 |
12 Sep 2024 | 1747.9 | 1738.9 | 1754.4 | 1731.65 |
11 Sep 2024 | 1727.75 | 1725.05 | 1742.75 | 1717.2 |
10 Sep 2024 | 1726.6 | 1710.5 | 1746.5 | 1710.5 |
09 Sep 2024 | 1708.95 | 1703 | 1722.05 | 1688.45 |
06 Sep 2024 | 1702.4 | 1714.8 | 1725 | 1696.2 |
05 Sep 2024 | 1709.25 | 1682.8 | 1715.9 | 1682 |
04 Sep 2024 | 1687.65 | 1677.1 | 1703.4 | 1666.1 |
03 Sep 2024 | 1687.85 | 1695.55 | 1715.8 | 1681.2 |
Date | Price |
---|---|
16 Sep 2024 | 1741.85 |
13 Sep 2024 | 1752.35 |
12 Sep 2024 | 1747.9 |
11 Sep 2024 | 1727.75 |
10 Sep 2024 | 1726.6 |
09 Sep 2024 | 1708.95 |
06 Sep 2024 | 1702.4 |
05 Sep 2024 | 1709.25 |
04 Sep 2024 | 1687.65 |
03 Sep 2024 | 1687.85 |
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
---|
Cipla Ltd | 2.4 | 5.3 | 5.4 | 11.6 | 33.8 | 74.0 | 252.8 | 167.8 |
Torrent Pharmaceuticals Ltd | 0.8 | 3.2 | 19.6 | 34.5 | 83.2 | 121.9 | 303.9 | 679.1 |
Sun Pharmaceuticals Industries Ltd | 2.3 | 6.9 | 22.5 | 18.5 | 62.3 | 138.6 | 336.6 | 133.5 |
Glenmark Pharmaceuticals Ltd | 1.9 | 11.3 | 40.2 | 85.5 | 104.7 | 225.4 | 366.3 | 139.3 |
Zydus Lifesciences Ltd | 1.0 | -6.0 | 3.4 | 12.6 | 73.4 | 97.7 | 361.0 | 338.4 |
Divis Laboratories Ltd | 5.9 | 18.2 | 20.1 | 56.3 | 44.8 | 6.1 | 233.1 | 555.1 |
Entity | 1W |
---|---|
Cipla Ltd | 2.4 |
Torrent Pharmaceuticals Ltd | 0.8 |
Sun Pharmaceuticals Industries Ltd | 2.3 |
Glenmark Pharmaceuticals Ltd | 1.9 |
Zydus Lifesciences Ltd | 1.0 |
Divis Laboratories Ltd | 5.9 |
Last updated time: 17 Sep 11:41 AM
Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Sales | 9186 | 9103 | 9865 | 10641 | 10944 | 12305 | 11583 | 11813 |
Sales YoY Gr. | - | -0.9% | 8.4% | 7.9% | 2.8% | 12.4% | -5.9% | 2.0% |
Adj EPS | 39.29 | 28.49 | 32.78 | 27.5 | 34.38 | 35.21 | 13.37 | -50.8 |
YoY Gr. | - | -27.5% | 15.1% | -16.1% | 25.0% | 2.4% | -62.0% | -480.0% |
Adj Net Profit | 1109 | 804 | 925 | 776 | 970 | 994 | 377 | -1434 |
BVPS | 159.21 | 182.99 | 198.65 | 215.14 | 250.37 | 322.03 | 335.75 | 278.11 |
Parameter | 2017 |
---|---|
Sales | 9186 |
Sales YoY Gr. | - |
Adj EPS | 39.29 |
YoY Gr. | - |
Adj Net Profit | 1109 |
BVPS | 159.21 |
Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Return on Capital Emp. % | 15.34 | 18.25 | 20.41 | 14.75 | 14.71 | 13.7 | 14.7 | 15.77 | 9.75 | 12.05 |
Op. Profit Mgn % | 18.06 | 19.05 | 21.7 | 18.75 | 18.18 | 17.77 | 19.91 | 20.26 | 16.56 | 17.22 |
Net Profit Mgn % | 3.9 | 9.71 | 12.07 | 8.83 | 8.3 | 7.29 | 8.86 | 9.42 | 5.96 | -37.29 |
Debt to Equity % | 1.48 | 1.44 | 1.07 | 0.97 | 0.84 | 0.8 | 0.75 | 0.55 | 0.46 | 0.34 |
Parameter | 2015 |
---|---|
Return on Capital Emp. % | 15.34 |
Op. Profit Mgn % | 18.06 |
Net Profit Mgn % | 3.9 |
Debt to Equity % | 1.48 |
No data available
No data available
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...
Divis Laboratories Ltd
Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...
Cipla Ltd
The Company is in the business of manufacturing, developing, and marketing wide ...
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...
Zydus Lifesciences Ltd
The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadoda...
FAQs for of Glenmark Pharmaceuticals Ltd
What factors influence the share price of Glenmark Pharmaceuticals Ltd over time?
What are the key events that typically impact Glenmark Pharmaceuticals Ltd's share price history?
How do stock splits affect Glenmark Pharmaceuticals Ltd's share price history?
How do dividends impact the share price history of Glenmark Pharmaceuticals Ltd?
How do corporate announcements affect Glenmark Pharmaceuticals Ltd’s share price history?
How can I use technical analysis to understand Glenmark Pharmaceuticals Ltd’s share price history?
Unlimited trading at just
Rs. 199*